Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
3177
-
Total 13F shares, excl. options
-
1.88B
-
Shares change
-
-32.4M
-
Total reported value, excl. options
-
$217B
-
Value change
-
-$3.47B
-
Put/Call ratio
-
0.89
-
Number of buys
-
1328
-
Number of sells
-
-1521
-
Price
-
$115.39
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q2 2023
3,408 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q2 2023.
Merck & Co., Inc. - Common Stock (MRK) has 3,177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.88B shares
of 2.53B outstanding shares and own 74.41% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (244M shares), BlackRock Inc. (206M shares), STATE STREET CORP (119M shares), WELLINGTON MANAGEMENT GROUP LLP (77.2M shares), GEODE CAPITAL MANAGEMENT, LLC (52.7M shares), MORGAN STANLEY (39.2M shares), FMR LLC (39M shares), BANK OF AMERICA CORP /DE/ (37.3M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (30.7M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (29.4M shares).
This table shows the top 3177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.